Syneos Health, LLC Sustainability Profile
Syneos Health, LLC, a leading biopharmaceutical solutions organisation headquartered in the United States, has been at the forefront of the healthcare industry since its founding in 2018. With a strong presence in North America, Europe, and Asia, Syneos Health offers a unique blend of clinical and commercial services designed to accelerate the delivery of innovative therapies to market. The company specialises in providing integrated solutions that encompass clinical development, commercialisation, and consulting services. Syneos Health distinguishes itself through its commitment to harnessing data and technology, enabling clients to navigate the complexities of drug development efficiently. Recognised for its strategic approach, the company has achieved significant milestones, positioning itself as a trusted partner for biopharmaceutical companies worldwide.
DitchCarbon Score
How does Syneos Health, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Syneos Health, LLC's score of 62 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Syneos Health, LLC's reported carbon emissions
In 2024, Syneos Health, LLC reported total carbon emissions of approximately 325,379,000 kg CO2e from Scope 1 and Scope 2 sources combined, with Scope 1 emissions at about 61,474,000 kg CO2e and Scope 2 emissions at approximately 263,905,000 kg CO2e. Additionally, their Scope 3 emissions reached about 901,520,000 kg CO2e. Comparatively, in 2023, the company recorded total emissions of around 410,755,000 kg CO2e for Scope 1 and Scope 2, with Scope 1 at approximately 86,910,000 kg CO2e and Scope 2 at about 323,845,000 kg CO2e. Scope 3 emissions for that year were approximately 854,936,000 kg CO2e. Despite these figures, Syneos Health has not disclosed specific reduction targets or initiatives as part of their climate commitments. The emissions data is cascaded from their parent company, Syneos Health, Inc., indicating a corporate family relationship that influences their sustainability reporting. Overall, while Syneos Health, LLC has made strides in emissions reporting, further clarity on reduction strategies and commitments would enhance their climate action profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 86,910,000 | 00,000,000 |
| Scope 2 | 323,845,000 | 000,000,000 |
| Scope 3 | 854,936,000 | 000,000,000 |
How Carbon Intensive is Syneos Health, LLC's Industry?
How Carbon Intensive is Syneos Health, LLC's Location?
Syneos Health, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Syneos Health, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
